• Home
  • Study Details
Not currently enrolling

NO FEAR-BE: Barrett's Esophagus Ablation Study

This research study is looking at a newer treatment option for Barrett's Esophagus (BE) which uses Nitrous Oxide to freeze unwanted tissue. The most commonly used treatment method is Radiofrequency Ablation (RFA) which uses heat to destroy the pre-cancerous tissue. Nitrous Oxide ablation using the C2 CryoBalloon Focal Ablation System, an FDA cleared device, is another, newer way of treating Barrett's Esophagus. To evaluate the newer treatment, we are enrolling patients who are not responding as well as expected to RFA. Patients with at least 2 or more previous RFA treatments who still have BE may be eligible.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is not currently enrolling.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Nicholas Shaheen
Center for Gastrointestinal Biology and Disease

Study Type

Clinical or Medical
Observational

Study Topics

Stomach, Digestion and Gut Health

IRB Number

18-0388

ClinicalTrials.gov

NCT03554356

Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research